Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Onset of high blood pressure might be possible after the start of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis.

Onset of high blood pressure might be possible after the start of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis.

Resource Type

CF Research News

Authors

Andrea Gramegna, Claudia De Petro, Gloria Leonardi, Martina Contarini, Francesco Amati, Roberto Meazza, Stefano Carugo, Francesco Blasi

References

J Cyst Fibros. 2022 Apr 18;S1569-1993(22)00099-6. doi: 10.1016/j.jcf.2022.04.010.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Theme

Care of patients with CF [3]
Endocrinology [4]

Keywords

adverse events [5]
Elexacaftor/tezacaftor/ivacaftor [6]
Systemic arterial hypertension [7]

Date

Monday, April 18, 2022

Featured resource article

No

Resource - Guideline Type

Other Guidelines [8]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/onset-high-blood-pressure-might-be-possible-after-start

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-21-00521R2_FINAL_Gramegna_210522.pdf [2] https://pubmed.ncbi.nlm.nih.gov/35450770/ [3] https://www.ecfs.eu/research-article-themes/care-patients-cf [4] https://www.ecfs.eu/research-article-themes/endocrinology [5] https://www.ecfs.eu/research-article-keywords/adverse-events [6] https://www.ecfs.eu/research-article-keywords/elexacaftortezacaftorivacaftor [7] https://www.ecfs.eu/research-article-keywords/systemic-arterial-hypertension [8] https://www.ecfs.eu/resource-guideline-type/other-guidelines